NSE filing, NSE: CREST. Summary written from the filing by ALFA Finder's alert engine.
Crest Ventures Ltd: key numbers
- Share price
- ₹347.30
- Market cap
- ₹988.1 Cr
- Revenue (annual)
- ₹159.1 Cr
- Net profit (annual)
- ₹46.83 Cr
- P/E (TTM)
- 28.7×Sector 19.7×
- Promoter holding
- 69.84%+0.00% QoQ
- FII holding
- 1.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crest Ventures Ltd
All →Crest Ventures Board Meeting Date
Crest Ventures will hold a board meeting on November 5, 2026. The agenda includes unaudited standalone and consolidated results for the quarter and half year.
Crest Ventures Other Announcement
Crest Ventures Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Crest Ventures Debt & Borrowing
Crest Ventures reported its half-yearly outstanding NCD statement for September 30, 2026. ₹100 Crore in 12% NCDs remain outstanding, maturing June 2027.
Crest Ventures Debt & Borrowing: ₹3.02 Cr
Crest Ventures Ltd paid ₹3.02 Crore quarterly interest on its 12% NCDs (12CVL27). The payment was made on the due date of 23 September 2026.
- Value
- ₹3.02 Cr
Crest Ventures Annual General Meeting
Crest Ventures Limited filed the minutes of its 44th Annual General Meeting held on August 22, 2026. The meeting covered adoption of financials and dividend approval.
Crest Ventures Annual General Meeting
Crest Ventures held its 44th Annual General Meeting on August 22, 2026, to transact business items and provide management updates on company performance.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.